Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Primary Immunodeficiency
How do you approach the decision between lentiviral gene therapy, enzyme-replacement therapy, or allogeneic hematopoietic stem-cell transplantation for managing patients with ADA-SCID?
Related Questions
How often are you performing CT screening in CVID patients to screen for ILD?
For patients with progessive CKD with comorbid conditions, do you adjust IVIG or switch to SCIG to prevent further progession in GFR reduction?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
Is there any genetic testing available for the CDHR3 receptor?
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
In a patient with selective IgM deficiency who is completely asymptomatic in terms of infections, what is your typical laboratory work up?
When a patient has CVID and is then diagnosed with lymphoma receiving ongoing chemotherapy, how do you manage the trough levels?
Do you recommend weekly SQ immunoglobulin replacement for an asplenic patient who only responded to 4/23 pneumococcal serotypes after the Prevnar 20 vaccine?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Would you consider the use of ruxolitinib for tumor fevers and leukocytosis?
